[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Soleno Therapeutics, Inc. Common Stock (SLNO)
Soleno Therapeutics (SLNO) sees increased social buzz and engagements, with recent posts discussing competitor data, potential acquisitions, and analyst ratings, while the stock experiences some price volatility.
About Soleno Therapeutics, Inc. Common Stock
Soleno Therapeutics, Inc. is a pharmaceutical company focused on developing treatments for rare diseases.
Soleno Therapeutics, Inc. Common Stock uses the ticker $SLNO for trading. Listed in the Stocks category.
Insights
- Soleno Therapeutics, Inc. Common Stock (SLNO) trading volume is up XXXXX% from the previous week.
- Soleno Therapeutics, Inc. Common Stock (SLNO) social dominance is up 1246% from the previous week.
- Soleno Therapeutics, Inc. Common Stock (SLNO) engagements is up XXXXXX% from the previous week.
- Soleno Therapeutics, Inc. Common Stock (SLNO) posts created is up XX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price has seen recent volatility, influenced by short-seller reports and drug safety concerns, but analyst ratings, acquisition rumors, and share repurchase agreements are providing some support, alongside positive social media sentiment regarding potential catalysts.
24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXX%
1-Year High: $XXXXX on 2025-07-09
1-Year Low: $XXXXX on 2025-01-14
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Soleno Therapeutics, Inc. Common Stock (SLNO) is currently AltRank #290 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +30
X Month: XXX +488
X Months: XXX -XX
1-Year High: XXXXX on 2025-08-14
1-Year Low: XX on 2025-09-24
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX +4
1-Year High: XX on 2025-05-15
1-Year Low: XX on 2025-09-15
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +103%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +179%
X Year: XXXXXXXXX +269%
1-Year High: XXXXXXX on 2025-11-05
1-Year Low: XXX on 2024-12-29
Engagements by network (24h): Reddit: X X: XXXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +211%
X Year: XXXXX +319%
1-Year High: XXX on 2025-11-08
1-Year Low: XX on 2025-02-02
Mentions by network (24h): Reddit: X X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Soleno Therapeutics, Inc. Common Stock (SLNO) in the last XX hours which is up XXXX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +209%
X Year: XXXXX +212%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-02-02
The most influential creators that mention Soleno Therapeutics, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @seedy19tron | X | XXXXX | XX | XXXXXX |
| @richtrades100 | X | XXXXX | X | XXXXX |
| @avidresearch | X | XXXXXX | X | XXXXX |
| @Quantumup1 | X | XXXXX | X | XXXXX |
| @NicholasChoupak | X | X | X | XXXXX |
| @AgonInvestments | X | XXX | X | XXX |
| @BuyTheUgly | X | XX | X | XXX |
| @ScorpionFund | X | XXXXXX | X | XXX |
| @BalaBioResearch | X | XXXXX | X | XX |
| @linhnguyen64143 | XX | XX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% +3%
1-Year High: XXX% on 2024-12-22
1-Year Low: XX% on 2025-09-10
Most Supportive Themes:
- Goldman Sachs Initiates Buy Rating: (10%) Goldman Sachs has initiated coverage of Soleno Therapeutics with a Buy rating, signaling positive institutional sentiment.
- Competitor Setback: (15%) A competitor's setback in a similar therapeutic area is likely contributing to positive market share gains for Soleno Therapeutics.
- Acquisition Rumors: (20%) Speculation about potential acquisition of Soleno Therapeutics is circulating, driven by rumors and analyst reports, suggesting investor interest.
Most Critical Themes:
- Recent Price Decrease: (5%) The stock price has experienced a decrease in the last XX hours, indicating recent negative price action.
- Negative Sentiment Shift: (10%) Despite overall positive sentiment, recent negative sentiment and a price decrease suggest potential volatility and a possible correction.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.062%
X Month: XXXXX% -XXXXXX%
X Months: XXXXX% +0.012%
X Year: XXXXX% +0.01%
1-Year High: XXXXX% on 2025-11-10
1-Year Low: XXXXXX% on 2025-09-06
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-11-06
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$6.10%
X Month: $XXXXXXXXXXXXX +$1.30%
X Months: $XXXXXXXXXXXXX -$34%
1-Year High: $XXXXXXXXXXXXX on 2025-07-09
1-Year Low: $XXXXXXXXXXXXX on 2025-03-21
Top Soleno Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"BofA $RYTM's PT to $XXX from $XXX reiterated at a Buy rating and said 'Encouraging Early BMI and Hyperphagia Reduction SignalModel Changes' $SLNO $AARD Morgan StanleyPT to $XXX from $XXX reit'd at Buy/said Preliminary Ph2 setmelanotide data in PWS indicate promising and consistent signs of activity (BMI and hyperphagia) despite a challenging population supporting advancement into Ph3. We view early data as encouraging indicating potential to expansion into another blockbuster opportunity. Here's what else BofA had to say:"
X Link @Quantumup1 2025-12-11T18:28Z 3926 followers, 1181 engagements
"how was good news for $rytm supposed to not drop $slno"
X Link @RudyResearch 2025-12-11T16:59Z XXX followers, XXX engagements
"Strong performance from core positions $KKR and $STZ. Also very interesting data from $RYTM substantial upside ahead for $SLNO"
X Link @AgonInvestments 2025-12-11T16:57Z XXX followers, XXX engagements
"Where is money flowing today $PL $RYTM $PPTA $ENVA $W $EAT $MOS $RCL $MTN $FND $YUM $BLTE $VFC $NCLH $AMR $BWIN $UGP $RGC $CCL $LION $CF $PAC $AIG $AXTA $PLAB $ROIV $CNC $CUK $UPWK $BCPC $AG $BHC $PVH $SLNO $NUVB $NTR $HUM $MOH $STVN $OLLI $LII $SATS"
X Link @FrancesJatkfc 2025-12-11T16:49Z 1778 followers, XXX engagements